These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22187235)

  • 1. The effects of a bidirectional cavo-tricuspid isthmus block in persistent atrial fibrillation.
    Kim JB; Choi S; Joung B; Lee MH; Kim SS
    Yonsei Med J; 2012 Jan; 53(1):76-82. PubMed ID: 22187235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common atrial flutter and atrial fibrillation are not always two stages of the same disease. A long-term follow-up study in patients with atrial flutter treated with cavo-tricuspid isthmus ablation.
    Delise P; Sitta N; Corò L; Marras E; Sciarra L; Bocchino M; Berton G
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):800-5. PubMed ID: 17060805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
    Wazni O; Marrouche NF; Martin DO; Gillinov AM; Saliba W; Saad E; Klein A; Bhargava M; Bash D; Schweikert R; Erciyes D; Abdul-Karim A; Brachman J; Gunther J; Pisano E; Potenza D; Fanelli R; Natale A
    Circulation; 2003 Nov; 108(20):2479-83. PubMed ID: 14610012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
    Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
    J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
    Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
    Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).
    Stabile G; Bertaglia E; Senatore G; De Simone A; Zoppo F; Donnici G; Turco P; Pascotto P; Fazzari M; Vitale DF
    Eur Heart J; 2006 Jan; 27(2):216-21. PubMed ID: 16214831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.
    Kocheril AG; Calkins H; Sharma AD; Cher D; Stubbs HA; Block JE
    J Interv Card Electrophysiol; 2005 Apr; 12(3):189-97. PubMed ID: 15875109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
    Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of prior antiarrhythmic drug use on the success of atrial fibrillation catheter ablation.
    Wang M; Tellor KB; Ramaswamy K; Krainik AJ; Armbruster AL
    J Clin Pharm Ther; 2019 Oct; 44(5):708-714. PubMed ID: 31056776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical outcomes of patients who developed typical atrial flutter on class 1C anti arrhythmic medications treated with hybrid approach.
    Grossman L; Katz M; Beinart R; Nof E
    Clin Cardiol; 2019 Jul; 42(7):678-683. PubMed ID: 31056764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an individualized strategy of cavotricuspid isthmus ablation as an adjunct to atrial fibrillation ablation.
    Shah DC; Sunthorn H; Burri H; Gentil-Baron P
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):926-30. PubMed ID: 17655668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective ablation or isolation of all pulmonary veins in atrial fibrillation -- when and for whom?
    Walczak F; Szumowski L; Urbanek P; Szufladowicz E; Derejko P; Kułakowski P; Baranowski R; Bodalski R; Kepski R; Zagrodzka M; Onish K; Bestry I; Konka M; Kuśnierczyk B; Maryniak A
    Kardiol Pol; 2006 Jan; 64(1):26-35; discussion 36-7. PubMed ID: 16444625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
    Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
    Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after cavo-tricuspid isthmus ablation in patients with recurrent atrial fibrillation and drug-related typical atrial flutter.
    Bottoni N; Donateo P; Quartieri F; Tomasi C; Oddone D; Lolli G; Menozzi C; Brignole M
    Am J Cardiol; 2004 Aug; 94(4):504-8. PubMed ID: 15325941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.
    Reithmann C; Dorwarth U; Dugas M; Hahnefeld A; Ramamurthy S; Remp T; Steinbeck G; Hoffmann E
    Eur Heart J; 2003 Jul; 24(13):1264-72. PubMed ID: 12831821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation.
    Anastasio N; Frankel DS; Deyell MW; Zado E; Gerstenfeld EP; Dixit S; Cooper J; Lin D; Marchlinski FE; Callans DJ
    J Interv Card Electrophysiol; 2012 Oct; 35(1):57-61. PubMed ID: 22552760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of sinus rhythm after electrical cardioversion for recurrent atrial fibrillation following mitral valve surgery with or without associated radiofrequency ablation.
    van Breugel HN; Gelsomino S; de Vos CB; Accord RE; Tieleman RG; Lucà F; Rostagno C; Renzulli A; Parise O; Lorusso R; Crijns HJ; Maessen JG
    Int J Cardiol; 2014 Aug; 175(2):290-6. PubMed ID: 24882697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of factors affecting persistence of atrial fibrillation in patients with concomitant atrial flutter treated with percutaneous radiofrequency current ablation of the right atrial cavotricuspid isthmus.
    Chodór P; Białkowska B; Hapeta B; Bugała K; Kłyś J; Pruszkowska-Skrzep P; Sredniawa B; Kalarus Z
    Kardiol Pol; 2013; 71(3):247-52. PubMed ID: 23575779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.